International retrospective natural history study of LMNA-related congenital muscular dystrophy

Muscular dystrophies due to heterozygous pathogenic variants in LMNA gene cover a broad spectrum of clinical presentations and severity with an age of onset ranging from the neonatal period to adulthood. The natural history of these conditions is not well defined, particularly in patients with conge...

Descripción completa

Detalles Bibliográficos
Autores: Ben Yaou R; Yun P; Dabaj I; Norato G; Donkervoort S; Xiong H; Nascimento A; Maggi L; Sarkozy A; Monges S; Bertoli M; Komaki H; Mayer M; Mercuri E; Zanoteli E; Castiglioni C; Marini-Bettolo C; D'Amico A; Deconinck N; Desguerre I; Erazo-Torricelli R; Gurgel-Giannetti J; Ishiyama A; Kleinsteuber KS; Lagrue E; Laugel V; Mercier S; Messina S; Politano L; Ryan MM; Sabouraud P; Schara U; Siciliano G; Vercelli L; Voit T; Yoon G; Alvarez R; Muntoni F; Pierson TM; Gómez-Andrés D; Reghan Foley A; Quijano-Roy S; Bönnemann CG; Bonne G
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2021
País:España
Institución:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:fsjd.fundanetsuite.com:p19860
Acceso en línea:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19860
Nivel de acceso:Acceso abierto
Palabra clave:laminopathies
striated muscle
LMNA
early onset
muscular dystrophy
_version_ 1878737302655598592
author Ben Yaou R
author2 Yun P
Dabaj I
Norato G
Donkervoort S
Xiong H
Nascimento A
Maggi L
Sarkozy A
Monges S
Bertoli M
Komaki H
Mayer M
Mercuri E
Zanoteli E
Castiglioni C
Marini-Bettolo C
D'Amico A
Deconinck N
Desguerre I
Erazo-Torricelli R
Gurgel-Giannetti J
Ishiyama A
Kleinsteuber KS
Lagrue E
Laugel V
Mercier S
Messina S
Politano L
Ryan MM
Sabouraud P
Schara U
Siciliano G
Vercelli L
Voit T
Yoon G
Alvarez R
Muntoni F
Pierson TM
Gómez-Andrés D
Reghan Foley A
Quijano-Roy S
Bönnemann CG
Bonne G
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Alvarez R
Ben Yaou R
Bertoli M
Bonne G
Bönnemann CG
Castiglioni C
D'Amico A
Dabaj I
Deconinck N
Desguerre I
Donkervoort S
Erazo-Torricelli R
Gurgel-Giannetti J
Gómez-Andrés D
Ishiyama A
Kleinsteuber KS
Komaki H
Lagrue E
Laugel V
Maggi L
Marini-Bettolo C
Mayer M
Mercier S
Mercuri E
Messina S
Monges S
Muntoni F
Nascimento A
Norato G
Pierson TM
Politano L
Quijano-Roy S
Reghan Foley A
Ryan MM
Sabouraud P
Sarkozy A
Schara U
Siciliano G
Vercelli L
Voit T
Xiong H
Yoon G
Yun P
Zanoteli E
author_facet Ben Yaou R
Yun P
Dabaj I
Norato G
Donkervoort S
Xiong H
Nascimento A
Maggi L
Sarkozy A
Monges S
Bertoli M
Komaki H
Mayer M
Mercuri E
Zanoteli E
Castiglioni C
Marini-Bettolo C
D'Amico A
Deconinck N
Desguerre I
Erazo-Torricelli R
Gurgel-Giannetti J
Ishiyama A
Kleinsteuber KS
Lagrue E
Laugel V
Mercier S
Messina S
Politano L
Ryan MM
Sabouraud P
Schara U
Siciliano G
Vercelli L
Voit T
Yoon G
Alvarez R
Muntoni F
Pierson TM
Gómez-Andrés D
Reghan Foley A
Quijano-Roy S
Bönnemann CG
Bonne G
author_role author
collection r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
description Muscular dystrophies due to heterozygous pathogenic variants in LMNA gene cover a broad spectrum of clinical presentations and severity with an age of onset ranging from the neonatal period to adulthood. The natural history of these conditions is not well defined, particularly in patients with congenital or early onset who arguably present with the highest disease burden. Thus the definition of natural history endpoints along with clinically revelant outcome measures is essential to establishing both clinical care planning and clinical trial readiness for this patient group. We designed a large international cross-sectional retrospective natural history study of patients with genetically proven muscle laminopathy who presented with symptoms before two years of age intending to identify and characterize an optimal clinical trial cohort with pertinent motor, cardiac and respiratory endpoints. Quantitative statistics were used to evaluate associations between LMNA variants and distinct clinical events. The study included 151 patients (median age at symptom onset 0.9 years, range: 0.0-2.0). Age of onset and age of death were significantly lower in patients who never acquired independent ambulation compared to patients who achieved independent ambulation. Most of the patients acquired independent ambulation (n = 101, 66.9%), and subsequently lost this ability (n = 86; 85%). The age of ambulation acquisition (median: 1.2 years, range: 0.8-4.0) and age of ambulation loss (median: 7 years, range: 1.2-38.0) were significantly associated with the age of the first respiratory interventions and the first cardiac symptoms. Respiratory and gastrointestinal interventions occurred during first decade while cardiac interventions occurred later. Genotype-phenotype analysis showed that the most common mutation, p.Arg249Trp (20%), was significantly associated with a more severe disease course. This retrospective natural history study of early onset LMNA-related muscular dystrophy confirms the progressive nature of the disorder, initially involving motor symptoms prior to onset of other symptoms (respiratory, orthopaedic, cardiac and gastrointestinal). The study also identifies subgroups of patients with a range of long-term outcomes. Ambulatory status was an important mean of stratification along with the presence or absence of the p.Arg249Trp mutation. These categorizations will be important for future clinical trial cohorts. Finally, this study furthers our understanding of the progression of early onset LMNA-related muscular dystrophy and provides important insights into the anticipatory care needs of LMNA-related respiratory and cardiac manifestations.
eu_rights_str_mv openAccess
format article
id ES_9dbf918cfa251f0fd2cd905edf888b84
institution Fundació Sant Joan de Déu
instname_str Fundació Sant Joan de Déu
network_acronym_str ES
network_name_str España
oai_identifier_str oai:fsjd.fundanetsuite.com:p19860
publishDate 2021
publishDateSort 2021
publisher OXFORD UNIV PRESS
publisherStr OXFORD UNIV PRESS
reponame_str r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
spelling International retrospective natural history study of LMNA-related congenital muscular dystrophy Ben Yaou R Yun P Dabaj I Norato G Donkervoort S Xiong H Nascimento A Maggi L Sarkozy A Monges S Bertoli M Komaki H Mayer M Mercuri E Zanoteli E Castiglioni C Marini-Bettolo C D'Amico A Deconinck N Desguerre I Erazo-Torricelli R Gurgel-Giannetti J Ishiyama A Kleinsteuber KS Lagrue E Laugel V Mercier S Messina S Politano L Ryan MM Sabouraud P Schara U Siciliano G Vercelli L Voit T Yoon G Alvarez R Muntoni F Pierson TM Gómez-Andrés D Reghan Foley A Quijano-Roy S Bönnemann CG Bonne G laminopathies striated muscle LMNA early onset muscular dystrophy Muscular dystrophies due to heterozygous pathogenic variants in LMNA gene cover a broad spectrum of clinical presentations and severity with an age of onset ranging from the neonatal period to adulthood. The natural history of these conditions is not well defined, particularly in patients with congenital or early onset who arguably present with the highest disease burden. Thus the definition of natural history endpoints along with clinically revelant outcome measures is essential to establishing both clinical care planning and clinical trial readiness for this patient group. We designed a large international cross-sectional retrospective natural history study of patients with genetically proven muscle laminopathy who presented with symptoms before two years of age intending to identify and characterize an optimal clinical trial cohort with pertinent motor, cardiac and respiratory endpoints. Quantitative statistics were used to evaluate associations between LMNA variants and distinct clinical events. The study included 151 patients (median age at symptom onset 0.9 years, range: 0.0-2.0). Age of onset and age of death were significantly lower in patients who never acquired independent ambulation compared to patients who achieved independent ambulation. Most of the patients acquired independent ambulation (n = 101, 66.9%), and subsequently lost this ability (n = 86; 85%). The age of ambulation acquisition (median: 1.2 years, range: 0.8-4.0) and age of ambulation loss (median: 7 years, range: 1.2-38.0) were significantly associated with the age of the first respiratory interventions and the first cardiac symptoms. Respiratory and gastrointestinal interventions occurred during first decade while cardiac interventions occurred later. Genotype-phenotype analysis showed that the most common mutation, p.Arg249Trp (20%), was significantly associated with a more severe disease course. This retrospective natural history study of early onset LMNA-related muscular dystrophy confirms the progressive nature of the disorder, initially involving motor symptoms prior to onset of other symptoms (respiratory, orthopaedic, cardiac and gastrointestinal). The study also identifies subgroups of patients with a range of long-term outcomes. Ambulatory status was an important mean of stratification along with the presence or absence of the p.Arg249Trp mutation. These categorizations will be important for future clinical trial cohorts. Finally, this study furthers our understanding of the progression of early onset LMNA-related muscular dystrophy and provides important insights into the anticipatory care needs of LMNA-related respiratory and cardiac manifestations. OXFORD UNIV PRESS https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19860
spellingShingle International retrospective natural history study of LMNA-related congenital muscular dystrophy
Ben Yaou R
laminopathies
striated muscle
LMNA
early onset
muscular dystrophy
status_str publishedVersion
title International retrospective natural history study of LMNA-related congenital muscular dystrophy
title_full International retrospective natural history study of LMNA-related congenital muscular dystrophy
title_fullStr International retrospective natural history study of LMNA-related congenital muscular dystrophy
title_full_unstemmed International retrospective natural history study of LMNA-related congenital muscular dystrophy
title_short International retrospective natural history study of LMNA-related congenital muscular dystrophy
title_sort International retrospective natural history study of LMNA-related congenital muscular dystrophy
topic laminopathies
striated muscle
LMNA
early onset
muscular dystrophy
topic_facet laminopathies
striated muscle
LMNA
early onset
muscular dystrophy
url https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19860